These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 14998995)

  • 21. Characterization of 5-HT3 receptor mutations identified in schizophrenic patients.
    Thompson AJ; Sullivan NL; Lummis SC
    J Mol Neurosci; 2006; 30(3):273-81. PubMed ID: 17401153
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The binding orientations of structurally-related ligands can differ; A cautionary note.
    Ruepp MD; Wei H; Leuenberger M; Lochner M; Thompson AJ
    Neuropharmacology; 2017 Jun; 119():48-61. PubMed ID: 28137449
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Loop B is a major structural component of the 5-HT3 receptor.
    Thompson AJ; Lochner M; Lummis SC
    Biophys J; 2008 Dec; 95(12):5728-36. PubMed ID: 18931259
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comprehensive study on the 5-hydroxytryptamine(3A) receptor binding of agonists serotonin and m-chlorophenylbiguanidine.
    Hazai E; Joshi P; Skoviak EC; Suryanarayanan A; Schulte MK; Bikadi Z
    Bioorg Med Chem; 2009 Aug; 17(16):5796-805. PubMed ID: 19640719
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The molecular basis of the structure and function of the 5-HT3 receptor: a model ligand-gated ion channel (review).
    Reeves DC; Lummis SC
    Mol Membr Biol; 2002; 19(1):11-26. PubMed ID: 11989819
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of critical residues in loop E in the 5-HT3ASR binding site.
    Venkataraman P; Venkatachalan SP; Joshi PR; Muthalagi M; Schulte MK
    BMC Biochem; 2002 Jun; 3():15. PubMed ID: 12079500
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structural basis of ligand recognition in 5-HT3 receptors.
    Kesters D; Thompson AJ; Brams M; van Elk R; Spurny R; Geitmann M; Villalgordo JM; Guskov A; Danielson UH; Lummis SC; Smit AB; Ulens C
    EMBO Rep; 2013 Jan; 14(1):49-56. PubMed ID: 23196367
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular determinants of single-channel conductance and ion selectivity in the Cys-loop family: insights from the 5-HT3 receptor.
    Peters JA; Hales TG; Lambert JJ
    Trends Pharmacol Sci; 2005 Nov; 26(11):587-94. PubMed ID: 16194573
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The binding characteristics and orientation of a novel radioligand with distinct properties at 5-HT3A and 5-HT3AB receptors.
    Thompson AJ; Verheij MH; Verbeek J; Windhorst AD; de Esch IJ; Lummis SC
    Neuropharmacology; 2014 Nov; 86():378-88. PubMed ID: 25174552
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Cys-loop superfamily of ligand-gated ion channels: the impact of receptor structure on function.
    Connolly CN; Wafford KA
    Biochem Soc Trans; 2004 Jun; 32(Pt3):529-34. PubMed ID: 15157178
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A single ring of charged amino acids at one end of the pore can control ion selectivity in the 5-HT3 receptor.
    Thompson AJ; Lummis SC
    Br J Pharmacol; 2003 Sep; 140(2):359-65. PubMed ID: 12970096
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Spatial orientation of the antagonist granisetron in the ligand-binding site of the 5-HT3 receptor.
    Yan D; White MM
    Mol Pharmacol; 2005 Aug; 68(2):365-71. PubMed ID: 15914697
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular cloning, functional expression, and pharmacological characterization of 5-hydroxytryptamine3 receptor cDNA and its splice variants from guinea pig.
    Lankiewicz S; Lobitz N; Wetzel CH; Rupprecht R; Gisselmann G; Hatt H
    Mol Pharmacol; 1998 Feb; 53(2):202-12. PubMed ID: 9463477
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Proline Residues in the Transmembrane/Extracellular Domain Interface Loops Have Different Behaviors in 5-HT
    Mosesso R; Dougherty DA; Lummis SCR
    ACS Chem Neurosci; 2019 Jul; 10(7):3327-3333. PubMed ID: 31273982
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of charged residues in coupling ligand binding and channel activation in the extracellular domain of the glycine receptor.
    Absalom NL; Lewis TM; Kaplan W; Pierce KD; Schofield PR
    J Biol Chem; 2003 Dec; 278(50):50151-7. PubMed ID: 14525990
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of Residues in the 5-HT
    Mesoy S; Jeffreys J; Lummis SCR
    ACS Chem Neurosci; 2019 Jul; 10(7):3167-3172. PubMed ID: 30835437
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Arginine 246 of the pretransmembrane domain 1 region alters 2,2,2-trichloroethanol action in the 5-hydroxytryptamine3A receptor.
    Hu XQ; Peoples RW
    J Pharmacol Exp Ther; 2008 Mar; 324(3):1011-8. PubMed ID: 18094321
    [TBL] [Abstract][Full Text] [Related]  

  • 38. X-ray structure of the mouse serotonin 5-HT3 receptor.
    Hassaine G; Deluz C; Grasso L; Wyss R; Tol MB; Hovius R; Graff A; Stahlberg H; Tomizaki T; Desmyter A; Moreau C; Li XD; Poitevin F; Vogel H; Nury H
    Nature; 2014 Aug; 512(7514):276-81. PubMed ID: 25119048
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The extracellular subunit interface of the 5-HT3 receptors: a computational alanine scanning mutagenesis study.
    De Rienzo F; Barbosa AJ; Perez MA; Fernandes PA; Ramos MJ; Menziani MC
    J Biomol Struct Dyn; 2012; 30(3):280-98. PubMed ID: 22694192
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Galanthamine and non-competitive inhibitor binding to ACh-binding protein: evidence for a binding site on non-alpha-subunit interfaces of heteromeric neuronal nicotinic receptors.
    Hansen SB; Taylor P
    J Mol Biol; 2007 Jun; 369(4):895-901. PubMed ID: 17481657
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.